Post by X-Therma Inc.

From cell therapies and engineered tissues to xenotransplantation and next-generation organ preservation, a critical bottleneck persists across the field: How do we reliably preserve, transport, and deliver living medicines when and where they're needed? We're thrilled to be at BIO International Convention 2026, engaging with industry leaders to help solve this challenge. Meet the X-Therma Inc. Team: • Xiaoxi Wei, Ph.D., CEO & Co-Founder • MAHRUKH BANDAY PhD Senior VP, Commercialization • Isaac Arruda, MBA, Business Development Manager 🎙️Don't Miss Our Panel Xiaoxi will speak on: Xenotransplantation Enters the Clinic: The Next Frontier in Solving Organ Shortage 📅 June 22, 2026, 3:00 PM – 4:00 PM 📍 Room 24BC Joining Xiaoxi are fellow experts, Jonathan D. Grinstein Ph.D. (Inside Precision Medicine), Michael Curtis Ph.D. (eGenesis), Cameron Lillie-Liberto (Kidney Disease Patient Advocate), Jesse Roach, M.D. (National Kidney Foundation) and David K. Yang (Lux Capital). As xenotransplantation moves from laboratory to clinical reality, this panel will examine the scientific, regulatory, and commercial innovations required to bring gene-edited organ transplantation safely and sustainably into practice. We're advancing next-generation biopreservation technologies that extend preservation windows and enable broader delivery of cells, tissues, and organs, helping remove time and distance as barriers to patient access. 📩 Let's connect at BIO 2026. Reach out to discuss the future of biopreservation. See you there! #BIO2026 #RegenerativeMedicine #OrganTransplantation #Biopreservation #Xenotransplant #XTherma #Youhavetime